Compare AstraZeneca plc (AZN) vs JD.Com Inc (JD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs JD.Com Inc — how do they compare? AstraZeneca plc trades at $158.15 (market cap $248.14B), while JD.Com Inc trades at $31.45 (market cap $44.04B). The key difference: AstraZeneca plc is far larger — about 5.6× JD.Com Inc's market cap, and JD.Com Inc pays the higher dividend (3.13%). Which is the better fit depends on your goals.
| AZN | JD | |
|---|---|---|
Market Cap | $248.14B | $44.04B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $36.17 |
52-Week Low | $147.06 | $25.19 |
Enterprise Value | $275.41B | $30.10B |
Dividend Yield | 2.01% | 3.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →
